Press releases

15 December 2015
Result of AGM

15 December 2015
CHK1 Clinical Trial Applications

13 November 2015
Notice of AGM

26 October 2015
Final Results

15 September 2015
US and European Patent Grants for Aurora+FLT3

23 July 2015
CHK1 Research Update

First description of the CHK1 clinical development candidate published in peer-reviewed journal: New ‘chemotherapy booster’ could treat lung and pancreatic cancer

17 June 2015
FUNDING AWARD FROM INNOVATE UK

Award of up to £140,000 to investigate the potential of TYK2 inhibitors to treat adolescent leukaemia

28 May 2015
Placing

21 May 2015
Sareum Launches New Website

12 May 2015
Sareum to Present at BioTrinity 2015

07 May 2015
Early Conclusion of Equity Swap Agreement

16 March 2015
Change of Adviser

25 February 2015
Research & Co-Development Collaborations Update

25 February 2015
Half-yearly Report

20 January 2015
Further US Patent Grant for Sareum’s Kinase Inhibitors

  • @Sareumplc Latest tweet

    RT @sierraoncology: Sierra sponsors the DNA Damage Response Therapeutics Summit next week in Boston. On Jan 30, CSO Dr. Chris Hassig will p… via @Sareumplc
    View more